Skip to main
We’re doing some system maintenance
  1. /
  2. Stocks
  3. /
  4. CollPlant Biotechnologies Ltd - ADR
CLGN

Buy CLGN Stock

CLGN
See CLGN stock price and Buy/Sell CollPlant Biotechnologies Ltd - ADR with any amount of money. Discuss news and analysts' price predictions with the investor community.
Sign up to start investing
CLGN

CollPlant Biotechnologies Ltd - ADR (CLGN)

About CollPlant Biotechnologies Ltd - ADR (CLGN)

CollPlant Biotechnologies Ltd. operates as a regenerative and aesthetic medicine company. It engages in the research, development, manufacture, and marketing of medical products for tissue repair such as bioprinting of tissues and organs, and medical aesthetics. Its products include VergenixSTR, VergenixFG, and Collink.3D. The company was founded by Oded Shoseyov in June 2004 and is headquartered ...Read more
Market Cap
$77.64M
1 Year High
$23
Volume
18.71k
1 Year Low
$6.51
Price to Earnings Ratio
Open
$7.49
Dividend Rate
High
$7.91
Dividend Yield
Low
$7

Community

People who own or watch CLGN stock

CLGN Price Targets

What analysts think CLGN stock price will be.
$7.22
$20
177.0% Upside
$6$25

CLGN Stock Rating

What analysts recommend for CLGN stock, on a scale from 1(buy) to 5(sell).
Strong Buy1 / 5
BuyHoldSell

CLGN Stock Earnings

The value each CLGN share was expected to gain vs. the value that each CLGN share actually gained.
Expected
Actual

CLGN Stock News

Frequently Asked Questions (FAQ)

As of Sep 24, 2022, the market cap for CLGN stock is $77.64M

The 52-week high for CLGN stock is $23. The current CLGN stock price $7.22 is 68.61% below its 52-week high

The 52-week low for CLGN stock is $6.51. The current CLGN stock price $7.22 has increased 9.83% from its 52-week low

No, the CLGN stock does not pay dividends to its shareholders

The target price for CLGN stock is $20 based on the average of what a group of analyst think CLGN stock could be worth at a future date. This is not a prediction by Public.com

Buy CLGN Stock

CLGN
See CLGN stock price and Buy/Sell CollPlant Biotechnologies Ltd - ADR with any amount of money. Discuss news and analysts' price predictions with the investor community.
Sign up to start investing

Community

People who own or watch CLGN stock
  • Randy0106 avatar
  • Chaydo avatar
  • goon22 avatar
  • jso avatar
  • shivangsharma avatar
Check the background of this firm on FINRA’s BrokerCheck.

© Copyright 2022 Public Holdings, Inc. All Rights Reserved.

Market data powered by Xignite.

Securities are offered to self-directed customers by Open to the Public Investing, Inc. (“Open to the Public Investing”), a registered broker-dealer and member of FINRA & SIPC. Additional information about your broker can be found by clicking here. Open to Public Investing is a wholly-owned subsidiary of Public Holdings Inc. (“Public Holdings”). This is not an offer, solicitation of an offer or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Open to the Public Investing is not registered. Securities products offered by Open to the Public Investing are not FDIC insured.

Cryptocurrency execution and custody services are provided by Apex Crypto LLC (NMLS ID 1828849) through a software licensing agreement between Apex Crypto LLC and Public Crypto LLC. Apex Crypto is not a registered broker-dealer or a member of SIPC or FINRA. Cryptocurrencies are not securities and are not FDIC or SIPC insured. Apex Crypto is licensed to engage in virtual currency business activity by the New York State Department of Financial Services. Please ensure that you fully understand the risks involved before trading: Legal Disclosures

Commission-free trading of stocks and ETFs refers to $0 commissions for Open to the Public Investing self-directed individual cash brokerage accounts that trade the U.S. listed securities electronically. Keep in mind, that other fees such as regulatory fees, Premium subscription fees, wire transfer fees, and paper statement fees may apply to your brokerage account. Please see Open to the Public Investing’s Fee Schedule to learn more.

All investments involve the risk of loss and the past performance of a security or a financial product does not guarantee future results or returns.